Oxford Antibiotic Group (OxAG) is an innovative drug discovery and development company that brings together Austrian drug development expertise with Oxford’s excellence in Chemistry and Life Sciences. Founded by international experts, the company mission is to bring a novel “first-in-class” antibiotic to the pharmaceutical market. Based on its unique Logi-bioticTM platform, the company works on natural product derived therapies to treat multi-drug resistant infections. To meet current unmet medical needs, substances with new modes of action, good toxicity profile and easy chemistry are a core focus of the current activities. Oxford Antibiotic Group aims to become an innovative and reliable supplier of new anti-infective medicines for the global pharmaceutical industry.